Pulmonology Articles

Pulmonology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Heijerman H et al. – The authors review the current knowledge on devices for inhalation therapy with regard to optimal particle sizes and characteristics of wet nebulisers, dry powder and metered dose inhalers. Finally, they address the subject of testing new devices before market introduction.

Related Articles

Diabetes as a Determinant of Mortality in Cystic Fibrosis
Diabetes Care, 11/20/09    Relevance Score: 69%

Vitamin D supplementation for cystic fibrosis
Cochrane Reviews, 10/28/09    Relevance Score: 69%

Genetic Risk Factor for Liver Disease for Patients With Cystic Fibrosis
Gastroenterology, 10/27/09    Relevance Score: 69%

Inspire Announces Presentation at the North American Cystic Fibrosis Conference and Provides Enrollment Update for Phase 3 Cystic Fibrosis Trial
Inspire, 10/16/09    Relevance Score: 69%

Pulmonary nocardiosis in cystic fibrosis
Journal of Cystic Fibrosis, 10/07/09    Relevance Score: 69%

Today in Cystic Fibrosis...keeping you current

Prognostic Factors in Idiopathic Pulmonary Fibrosis
The American Journal of the Medical Sciences, 12/17/09

Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures
Lung Cellular and Molecular Physiology, 12/16/09

Decreased Levels of Secretory Leucoprotease Inhibitor in the Pseudomonas-Infected Cystic Fibrosis Lung Are Due to Neutrophil Elastase Degradation
Journal of Immunology, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address